Epithelioid trophoblastic tumor, Prognostic model, Clinicopathological characteristics, Progression-free survival
Sirolimus, mTOR inhibitor, intravenous leiomyomatosis, pulmonary benign metastatic leiomyomatosis, leiomyomatosis peritonealis disseminata